You just read:

At One Month Post-Launch, More than One-Quarter of Surveyed U.S. Medical Oncologists Have Prescribed Boehringer Ingelheim's Gilotrif for Non-Small-Cell Lung Cancer

News provided by

BioTrends Research Group

Dec 09, 2013, 10:23 ET